The Risk of Hepatotoxicity Associated with HAART/Anti-Tb Co-Treatment: A Case Control Study in a Central Ethiopian Referral Hospital

Minyahil Alebachew Woldu^1*#, Henok Demeke Getaneh^2#, Jimma Likisa Lenjisa², Gobezie Temesgen Tegegn², Gurmu Tesafye Umeta and Hunduma Dinsa Ayano²

¹Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia

²Clinical Pharmacy unit, Department of Pharmacy, Ambo University, Ambo, Ethiopia

^#Contributed equally to this work

^*Corresponding Author: Minyahil Alebachew Woldu, Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University, P.O. Box: 9086, Addis Ababa, Ethiopia, Tel: +251-91-2648527 Email: